Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.

Gang, E J

Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia. [electronic resource] - Oncogene Apr 2014 - 2169-78 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1476-5594

10.1038/onc.2013.169 doi


Animals
Antineoplastic Agents--pharmacology
Asparaginase--pharmacology
Bridged Bicyclo Compounds, Heterocyclic--pharmacology
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Dexamethasone--pharmacology
Down-Regulation--drug effects
Drug Resistance, Neoplasm
Drug Synergism
Humans
Inhibitor of Apoptosis Proteins--genetics
Mice
Mice, Inbred NOD
Mice, SCID
Mutation
Peptide Fragments--antagonists & inhibitors
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Pyrimidinones--pharmacology
Sialoglycoproteins--antagonists & inhibitors
Survivin
Vincristine--pharmacology
Wnt Signaling Pathway
Xenograft Model Antitumor Assays
beta Catenin--metabolism